Skip to main content
SpringerLink
Log in

Thymoma-Associated Paraneoplastic Myasthenia Gravis

  • Chapter
  • First Online:
Book cover Myasthenia Gravis and Related Disorders

Part of the book series: Current Clinical Neurology ((CCNEU))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    PS and AM are supported by European Union FP6 grants LSHB-CT-2003-503410 (Euro-Thymaide) and 2005105 (EuroMyasthenie), the NIH (International Thymectomy Trial, MGTX) grant MG31506 and grant 10-1740 of the Deutsche Krebshilfe.

REFERENCES

  1. Meager A, Visvalingam K, Peterson P, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3:e289.

    PubMed  Google Scholar 

  2. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975 [classical article]. Neurology. 1998;51:933–939.

    PubMed  Google Scholar 

  3. Tzartos SJ, Barkas T, Cung MT, et al. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev. 1998;163:89–120.

    PubMed  CAS  Google Scholar 

  4. Lee JY, Sung JJ, Cho JY, et al. MuSK antibody-positive, seronegative myasthenia gravis in Korea. J Clin Neurosci. 2006;13:353–355.

    PubMed  Google Scholar 

  5. Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol. 2005;18:519–525.

    PubMed  CAS  Google Scholar 

  6. Yeh JH, Chen WH, Chiu HC, Vincent A. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology. 2004;62:2131–2132.

    PubMed  Google Scholar 

  7. Bartoccioni E, Marino M, Evoli A, Ruegg MA, Scuderi F, Provenzano C. Identification of disease-specific autoantibodies in seronegative myasthenia gravis. Ann N Y Acad Sci. 2003;998:356–358.

    PubMed  CAS  Google Scholar 

  8. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7:365–368.

    PubMed  CAS  Google Scholar 

  9. Leite MI, Strobel P, Jones M, et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol. 2005;57:444–448.

    PubMed  Google Scholar 

  10. Willcox N. Myasthenia gravis. Curr Opin Immunol. 1993;5:910–917.

    PubMed  CAS  Google Scholar 

  11. Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330:1797–1810.

    PubMed  CAS  Google Scholar 

  12. Marx A, Wilisch A, Schultz A, Gattenlohner S, Nenninger R, Muller-Hermelink HK. Pathogenesis of myasthenia gravis. Virchows Arch. 1997;430:355–364.

    PubMed  CAS  Google Scholar 

  13. Chuang WY, Strobel P, Gold R, et al. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients. Ann Neurol. 2005;58:644–648.

    PubMed  CAS  Google Scholar 

  14. Willcox N, Schluep M, Ritter MA, Newsom-Davis J. The thymus in seronegative myasthenia gravis patients. J Neurol. 1991;238:256–261.

    PubMed  CAS  Google Scholar 

  15. Williams CL, Hay JE, Huiatt TW, Lennon VA. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. Lab Invest. 1992;66:331–336.

    PubMed  CAS  Google Scholar 

  16. Vincent A. Aetiological factors in development of myasthenia gravis. Adv Neuroimmunol. 1994;4:355–371.

    PubMed  CAS  Google Scholar 

  17. Muller-Hermelink HK, Marx A, T K. Thymus. In: Damjanov I LJ, ed. Anderson's Pathology (ed 10). St. Louis: Mosby; 1996:1218–1243.

    Google Scholar 

  18. Middleton G, Schoch EM. The prevalence of human thymic lymphoid follicles is lower in suicides. Virchows Arch. 2000;436:127–130.

    PubMed  CAS  Google Scholar 

  19. Roxanis I, Micklem K, Willcox N. True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis. J Neuroimmunol. 2001;112:163–173.

    PubMed  CAS  Google Scholar 

  20. Kirchner T, Schalke B, Melms A, von Kugelgen T, Muller-Hermelink HK. Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;52:237–257.

    PubMed  CAS  Google Scholar 

  21. Flores KG, Li J, Sempowski GD, Haynes BF, Hale LP. Analysis of the human thymic perivascular space during aging. J Clin Invest. 1999;104:1031–1039.

    PubMed  CAS  Google Scholar 

  22. Curnow J, Corlett L, Willcox N, Vincent A. Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response. J Neuroimmunol. 2001;115:127–134.

    PubMed  CAS  Google Scholar 

  23. Navaneetham D, Penn AS, Howard JF, Jr., Conti-Fine BM. Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the delta subunit. Muscle Nerve. 2001;24:203–210.

    PubMed  CAS  Google Scholar 

  24. Geuder KI, Marx A, Witzemann V, et al. Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis. Dev Immunol. 1992;2:69–75.

    PubMed  CAS  Google Scholar 

  25. Schluep M, Willcox N, Vincent A, Dhoot GK, Newsom-Davis J. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol. 1987;22:212–222.

    PubMed  CAS  Google Scholar 

  26. Bornemann A, Kirchner T. An immuno-electron-microscopic study of human thymic B cells. Cell Tissue Res. 1996;284:481–487.

    PubMed  CAS  Google Scholar 

  27. Meraouna A, Cizeron-Clairac G, Panse RL, et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood. 2006;108:432–440.

    PubMed  CAS  Google Scholar 

  28. Compston DA, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain. 1980;103:579–601.

    PubMed  CAS  Google Scholar 

  29. Degli-Esposti MA, Andreas A, Christiansen FT, Schalke B, Albert E, Dawkins RL. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics. 1992;35:355–364.

    PubMed  CAS  Google Scholar 

  30. Huang D, Shi FD, Giscombe R, Zhou Y, Ljunggren HG, Lefvert AK. Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis. Eur J Immunol. 2001;31:225–232.

    PubMed  CAS  Google Scholar 

  31. Skeie GO, Pandey JP, Aarli JA, Gilhus NE. TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol. 1999;56:457–461.

    PubMed  CAS  Google Scholar 

  32. Huang DR, Pirskanen R, Matell G, Lefvert AK. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis. J Neuroimmunol. 1999;94:165–171.

    PubMed  CAS  Google Scholar 

  33. Franciotta D, Cuccia M, Dondi E, Piccolo G, Cosi V. Polymorphic markers in MHC class II/III region: a study on Italian patients with myasthenia gravis. J Neurol Sci. 2001;190:11–16.

    PubMed  CAS  Google Scholar 

  34. Huang DR, Zhou YH, Xia SQ, Liu L, Pirskanen R, Lefvert AK. Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease. J Neuroimmunol. 1999;94:82–87.

    PubMed  CAS  Google Scholar 

  35. Garchon HJ, Djabiri F, Viard JP, Gajdos P, Bach JF. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci U S A. 1994;91:4668–4672.

    PubMed  CAS  Google Scholar 

  36. Djabiri F, Gajdos P, Eymard B, Gomez L, Bach JF, Garchon HJ. No evidence for an association of AChR beta-subunit gene (CHRNB1) with myasthenia gravis. J Neuroimmunol. 1997;78:86–89.

    PubMed  CAS  Google Scholar 

  37. Giraud M, Beaurain G, Yamamoto AM, et al. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology. 2001;57:1555–1560.

    PubMed  CAS  Google Scholar 

  38. Onodera J, Nakamura S, Nagano I, et al. Upregulation of Bcl-2 protein in the myasthenic thymus. Ann Neurol. 1996;39:521–528.

    PubMed  CAS  Google Scholar 

  39. Masunaga A, Arai T, Yoshitake T, Itoyama S, Sugawara I. Reduced expression of apoptosis-related antigens in thymuses from patients with myasthenia gravis. Immunol Lett. 1994;39:169–172.

    PubMed  CAS  Google Scholar 

  40. Moulian N, Bidault J, Truffault F, Yamamoto AM, Levasseur P, Berrih-Aknin S. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood. 1997;89:3287–3295.

    PubMed  CAS  Google Scholar 

  41. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet. 2001;357:2122–2128.

    PubMed  CAS  Google Scholar 

  42. Sempowski GD, Hale LP, Sundy JS, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol. 2000;164:2180–2187.

    PubMed  CAS  Google Scholar 

  43. Muller-Hermelink HK, Marx A. Thymoma. Curr Opin Oncol. 2000;12:426–433.

    PubMed  CAS  Google Scholar 

  44. Sommer N, Willcox N, Harcourt GC, Newsom-Davis J. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol. 1990;28:312–319.

    PubMed  CAS  Google Scholar 

  45. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Muller-Hermelink HK. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 1992;16:1153–1169.

    PubMed  CAS  Google Scholar 

  46. Marx A, Schultz A, Wilisch A, Helmreich M, Nenninger R, Muller-Hermelink HK. Paraneoplastic autoimmunity in thymus tumors. Dev Immunol. 1998;6:129–140.

    PubMed  CAS  Google Scholar 

  47. Nagvekar N, Moody AM, Moss P, et al. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes. J Clin Invest. 1998;101:2268–2277.

    PubMed  CAS  Google Scholar 

  48. Vincent A. Antibodies to ion channels in paraneoplastic disorders. Brain Pathol. 1999;9:285–291.

    PubMed  CAS  Google Scholar 

  49. Müller-Hermelink HK, Engel P, Kuo TT, et al. Tumours of the thymus: Introduction. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC, eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Lung, Thymus and Heart. Vol. 7. Lyon: IARC Press; 2004;145–151.

    Google Scholar 

  50. Marx A, Strobel P, Zettl A, et al. Thymomas. In: Travis MD, Brambilla E, Müller-Hermelink HK, Harris CC, eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Lung, Thymus and Heart. Vol. 7. Lyon: IARC Press; 2004;152–153.

    Google Scholar 

  51. Rosai J. Histological typing of tumours of the thymus (2nd ed.). Berlin and Heidelberg: Springer-Verlag; 1999.

    Google Scholar 

  52. Wekerle H, Ketelsen UP. Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet. 1977;1:678–680.

    PubMed  CAS  Google Scholar 

  53. Weinberg CB, Hall ZW. Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors. Proc Natl Acad Sci U S A. 1979;76:504–508.

    PubMed  CAS  Google Scholar 

  54. Geuder KI, Marx A, Witzemann V, Schalke B, Kirchner T, Muller-Hermelink HK. Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma. Lab Invest. 1992;66:452–458.

    PubMed  CAS  Google Scholar 

  55. Kaminski HJ, Kusner LL, Block CH. Expression of acetylcholine receptor isoforms at extraocular muscle endplates [published erratum appears in Invest Ophthalmol Vis Sci 1996 Jul;37(8):6A]. Invest Ophthalmol Vis Sci. 1996;37:345–351.

    PubMed  CAS  Google Scholar 

  56. MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis [see comments]. Ann Neurol. 1997;41:423–431.

    PubMed  CAS  Google Scholar 

  57. Scadding GK, Vincent A, Newsom-Davis J, Henry K. Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology. 1981;31:935–943.

    PubMed  CAS  Google Scholar 

  58. Nieto IP, Robledo JP, Pajuelo MC, et al. Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases [see comments]. Ann Thorac Surg. 1999;67:1568–1571.

    PubMed  CAS  Google Scholar 

  59. Tsuchida M, Yamato Y, Souma T, et al. Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis. Ann Thorac Surg. 1999;67:1563–1567.

    PubMed  CAS  Google Scholar 

  60. Meinl E, Klinkert WE, Wekerle H. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Am J Pathol. 1991;139:995–1008.

    PubMed  CAS  Google Scholar 

  61. Schonbeck S, Padberg F, Marx A, Hohlfeld R, Wekerle H. Transplantation of myasthenia gravis thymus to SCID mice. Ann N Y Acad Sci. 1993;681:66–73.

    PubMed  CAS  Google Scholar 

  62. Spuler S, Marx A, Kirchner T, Hohlfeld R, Wekerle H. Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells. Am J Pathol. 1994;145:766–770.

    PubMed  CAS  Google Scholar 

  63. Spuler S, Sarropoulos A, Marx A, Hohlfeld R, Wekerle H. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice. Am J Pathol. 1996;148:1359–1365.

    PubMed  CAS  Google Scholar 

  64. Baggi F, Nicolle M, Vincent A, Matsuo H, Willcox N, Newsom-Davis J. Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient. J Neuroimmunol. 1993;46:57–65.

    PubMed  CAS  Google Scholar 

  65. Melms A, Malcherek G, Gern U, et al. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha- subunit. Ann Neurol. 1992;31:311–318.

    PubMed  CAS  Google Scholar 

  66. Jermy A, Beeson D, Vincent A. Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Eur J Immunol. 1993;23:973–976.

    PubMed  CAS  Google Scholar 

  67. Salmon AM, Bruand C, Cardona A, Changeux JP, Berrih-Aknin S. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis. J Clin Invest. 1998;101:2340–2350.

    PubMed  CAS  Google Scholar 

  68. Melms A, Schalke BC, Kirchner T, Muller-Hermelink HK, Albert E, Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest. 1988;81:902–908.

    PubMed  CAS  Google Scholar 

  69. Hohlfeld R, Wekerle H. The immunopathogenesis of myasthenia gravis. In: Angel AG, ed. Myasthenia gravis and myasthenic disorders. Oxford: Oxford University Press; 1999:87–110.

    Google Scholar 

  70. Sims GP, Shiono H, Willcox N, Stott DI. Somatic hypermutation and selection of b cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol. 2001;167:1935–1944.

    PubMed  CAS  Google Scholar 

  71. Bernasconi P, Barberis M, Baggi F, et al. Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution. Am J Pathol. 2005;167:129–139.

    PubMed  CAS  Google Scholar 

  72. Vincent A, Willcox N, Hill M, Curnow J, MacLennan C, Beeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev. 1998;164:157–168.

    PubMed  CAS  Google Scholar 

  73. Willcox N, Schluep M, Ritter MA, Schuurman HJ, Newsom-Davis J, Christensson B. Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am J Pathol. 1987;127:447–460.

    PubMed  CAS  Google Scholar 

  74. Inoue M, Fujii Y, Okumura M, et al. T-cell development in human thymoma. Pathol Res Pract. 1999;195:541–547.

    PubMed  CAS  Google Scholar 

  75. Kadota Y, Okumura M, Miyoshi S, et al. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN- gamma). Clin Exp Immunol. 2000;121:59–68.

    PubMed  CAS  Google Scholar 

  76. Strobel P, Helmreich M, Kalbacher H, Muller-Hermelink HK, Marx A. Evidence for distinct mechanisms in the shaping of the CD4 T cell repertoire in histologically distinct myasthenia gravis-associated thymomas. Dev Immunol. 2001;8:279–290.

    PubMed  CAS  Google Scholar 

  77. Newsom-Davis J, Willcox N, Schluep M, et al. Immunological heterogeneity and cellular mechanisms in myasthenia gravis. Ann N Y Acad Sci. 1987;505:12–26.

    PubMed  CAS  Google Scholar 

  78. Fujii Y, Monden Y, Nakahara K, Hashimoto J, Kawashima Y. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology. 1984;34:1182–1186.

    PubMed  CAS  Google Scholar 

  79. Ströbel P, Murumagi A, Klein R, et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type I (APS-1). J Pathol. 2007;211:563–571.

    Google Scholar 

  80. Heino M, Peterson P, Kudoh J, et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun. 1999;257:821–825.

    PubMed  CAS  Google Scholar 

  81. Bjorses P, Halonen M, Palvimo JJ, et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet. 2000;66:378–392.

    PubMed  CAS  Google Scholar 

  82. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity. 2005;23:227–239.

    PubMed  CAS  Google Scholar 

  83. Ramsey C, Hassler S, Marits P, et al. Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator. Eur J Immunol. 2006;36:305–317.

    PubMed  CAS  Google Scholar 

  84. Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Hollander GA. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune- polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol. 2000;165:1976–1983.

    PubMed  CAS  Google Scholar 

  85. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol. 2003;4:350–354.

    PubMed  CAS  Google Scholar 

  86. Chuang W, Strobel P, Gold R, et al. A CTLA4high Genotype Is Associated with Myasthenia Gravis in Thymoma Patients. Ann Neurol. 2005;58:644–648.

    PubMed  CAS  Google Scholar 

  87. Carreno BM, Bennett F, Chau TA, et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol. 2000;165:1352–1356.

    PubMed  CAS  Google Scholar 

  88. Zettl A, Ströbel P, Wagner K, et al. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol. 2000;157:257–266.

    PubMed  CAS  Google Scholar 

  89. Takeuchi Y, Fujii Y, Okumura M, Inada K, Nakahara K, Matsuda H. Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus. Cell Immunol. 1995;161:181–187.

    PubMed  CAS  Google Scholar 

  90. Nenninger R, Schultz A, Vandekerckhove B, Hünig T, Müller-Hermelink HK, Marx A. Abnormal T lymphocyte development in myasthenia gravis-associated thymomas. New York, London: Plenum Press; 1997.

    Google Scholar 

  91. Nenninger R, Schultz A, Hoffacker V, et al. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab Invest. 1998;78:743–753.

    PubMed  CAS  Google Scholar 

  92. Strobel P, Helmreich M, Menioudakis G, et al. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. Blood. 2002;100:159–166.

    PubMed  CAS  Google Scholar 

  93. Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol. 2001;50:64–72.

    PubMed  CAS  Google Scholar 

  94. Hoffacker V, Schultz A, Tiesinga JJ, et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease [In Process Citation]. Blood. 2000;96:3872–3879.

    PubMed  CAS  Google Scholar 

  95. Sommer N, Harcourt GC, Willcox N, Beeson D, Newsom-Davis J. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology. 1991;41:1270–1276.

    PubMed  CAS  Google Scholar 

  96. Conti-Fine BM, Navaneetham D, Karachunski PI, et al. T cell recognition of the acetylcholine receptor in myasthenia gravis. Ann N Y Acad Sci. 1998;841:283–308.

    PubMed  CAS  Google Scholar 

  97. Schultz A, Hoffacker V, Wilisch A, et al. Neurofilament is an autoantigenic determinant in myasthenia gravis. Ann Neurol. 1999;46:167–175.

    PubMed  CAS  Google Scholar 

  98. Strobel P, Rosenwald A, Beyersdorf N, et al. Selective loss of regulatory T cells in thymomas. Ann Neurol. 2004;56:901–904.

    PubMed  Google Scholar 

  99. Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology. 2005;116:134–141.

    PubMed  CAS  Google Scholar 

  100. Aarli JA, Skeie GO, Mygland A, Gilhus NE. Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance. Ann N Y Acad Sci. 1998;841:505–515.

    PubMed  CAS  Google Scholar 

  101. Etienne M, Weimer LH. Immune-mediated autonomic neuropathies. Curr Neurol Neurosci Rep. 2006;6:57–64.

    PubMed  CAS  Google Scholar 

  102. Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004;10:7270–7275.

    PubMed  CAS  Google Scholar 

  103. Marx A, Kirchner T, Greiner A, Muller-Hermelink HK, Schalke B, Osborn M. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis. Lancet. 1992;339:707–708.

    PubMed  CAS  Google Scholar 

  104. Mygland A, Aarli JA, Matre R, Gilhus NE. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J Neurol Neurosurg Psychiatry. 1994;57:843–846.

    PubMed  CAS  Google Scholar 

  105. Mygland A, Kuwajima G, Mikoshiba K, Tysnes OB, Aarli JA, Gilhus NE. Thymomas express epitopes shared by the ryanodine receptor. J Neuroimmunol. 1995;62:79–83.

    PubMed  CAS  Google Scholar 

  106. Fukui Y, Ishimoto T, Utsuyama M, et al. Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity. 1997;6:401–410.

    PubMed  CAS  Google Scholar 

  107. Ashton-Rickardt PG, Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today. 1994;15:362–366.

    PubMed  CAS  Google Scholar 

  108. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17–27.

    PubMed  CAS  Google Scholar 

  109. Barton GM, Rudensky AY. Requirement for diverse, low-abundance peptides in positive selection of T cells. Science. 1999;283:67–70.

    PubMed  CAS  Google Scholar 

  110. Laufer TM, Fan L, Glimcher LH. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J Immunol. 1999;162:5078–5084.

    PubMed  CAS  Google Scholar 

  111. van Meerwijk JP, MacDonald HR. In vivo T-lymphocyte tolerance in the absence of thymic clonal deletion mediated by hematopoietic cells. Blood. 1999;93:3856–3862.

    PubMed  Google Scholar 

  112. Muller-Hermelink HK, Wilisch A, Schultz A, Marx A. Characterization of the human thymic microenvironment: lymphoepithelial interaction in normal thymus and thymoma. Arch Histol Cytol. 1997;60:9–28.

    PubMed  CAS  Google Scholar 

  113. Vincent A, Willcox N. The role of T-cells in the initiation of autoantibody responses in thymoma patients. Pathol Res Pract. 1999;195:535–540.

    PubMed  CAS  Google Scholar 

  114. Meager A, Vincent A, Newsom-Davis J, Willcox N. Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease [letter]. Lancet. 1997;350:1596–1597.

    PubMed  CAS  Google Scholar 

  115. Conti-Tronconi BM, McLane KE, Raftery MA, Grando SA, Protti MP. The nicotinic acetylcholine receptor: structure and autoimmune pathology. Crit Rev Biochem Mol Biol. 1994;29:69–123.

    PubMed  CAS  Google Scholar 

  116. Somnier FE. Exacerbation of myasthenia gravis after removal of thymomas [see comments]. Acta Neurol Scand. 1994;90:56–66.

    PubMed  CAS  Google Scholar 

  117. Marx A, O'Connor R, Geuder KI, et al. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas [see comments]. Lab Invest. 1990;62:279–286.

    PubMed  CAS  Google Scholar 

  118. Marx A, Wilisch A, Schultz A, et al. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis. Am J Pathol. 1996;148:1839–1850.

    PubMed  CAS  Google Scholar 

  119. Strobel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004;22:1501–1509.

    PubMed  Google Scholar 

  120. Lang KS, Recher M, Junt T, et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med. 2005;11:138–145.

    PubMed  CAS  Google Scholar 

  121. Maselli RA, Richman DP, Wollmann RL. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 1991;41:1497–1504.

    PubMed  CAS  Google Scholar 

  122. Evoli A, Minisci C, Di Schino C, et al. Thymoma in patients with MG: characteristics and long-term outcome. Neurology. 2002;59:1844–1850.

    PubMed  CAS  Google Scholar 

  123. Rickman OB, Parisi JE, Yu Z, Lennon VA, Vernino S. Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange. Mayo Clin Proc. 2000;75:1321–1326.

    PubMed  CAS  Google Scholar 

  124. Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology. 1999;53:1233–1239.

    PubMed  CAS  Google Scholar 

  125. Pande R, Leis AA. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve. 1999;22:1600–1602.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, University Medical Center Mannheim and University of Heidelberg, Mannheim, Germany

    Philipp Ströbel & Alexander Marx

  2. Department of Pathology, Chang Gung University, Taoyuan, Taiwan

    Wen-Yu Chuang

Authors
  1. Philipp Ströbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wen-Yu Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Marx
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ströbel, P., Chuang, WY., Marx, A. (2009). Thymoma-Associated Paraneoplastic Myasthenia Gravis. In: Myasthenia Gravis and Related Disorders. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-156-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-156-7_7

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-852-2

  • Online ISBN: 978-1-59745-156-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation